08:00–08:45		Meet the Expert Sessions
08:00	M01	Hematology
		Malgorzata Mikulska, FECMM, Italy & Alessandro Busca, Italy
08:00	M02	Peadiatrics
		Simone Cesaro, Italy & Adillia Warris, FECMM, UK
08:00	M03	Candida in the ICU
		Matteo Bassetti, Italy & Jean-François Timsit, France
08:00	M04	Diagnostics/Laboratory
		Alida Talento, Ireland & Michaela Lackner, FECMM, Austria
08:00	M05	Tropical
		Arunaloke Chakrabarti, FECMM, India & Rita Oladele, FECMM, Nigeria
09:00–10:00		Plenary Session 2—Highlights on Fungal Biology
		Chairs: Vishukumar Aimanianda, France & Don Sheppard, FECMM, Canada
08:50	PS 2.1	Candida
		Christophe D’Enfert, France
09:20	PS 2.2	Aspergillus
		Agostinho Carvalho, FECMM, Portugal
09:50	PS 2.3*	Lineage-Specific Behavioural Differences in Isolates of Candida auris
		Andrew Borman, UK
10:30–11:30		Plenary Session 3—One World One Guideline ECMM MSG-ERC (EFISG) ISHAM Guidelines Initiative
		Chairs: Martin Hoenigl, FECMM, Austria & John Perfect, USA
10:30	PS3.1	Mucormycosis
		Oliver Cornely, FECMM, Germany
10:45	PS3.2	Endemic
		George Thompson, USA
11:00	PS3.3	Rare Moulds
		Martin Hoenigl, FECMM, Austria
11:15	PS3.4	Rare Yeasts
		Sharon Chen, FECMM, Australia
11:30-12:30		Poster Session
14:15-15:45		Parallel Symposia 5–9
Symposium 5		Lung Transplantation
		Chairs: Shahid Husain, FECMM, Canada & Paolo Grossi, Italy
14:15	S05.1	Pretransplant Assessment
		Blandine Rammaert, France
14:35	S05.2	Pathophysiology and Epidemiology of Invasive Aspergillosis in Lung Transplant Recipients
		Claire Aguilar, France
14:55	S05.3	Current Guidelines
		Shahid Husain, FECMM, Canada
15:15	S05.4	Prophylaxis
		John Perfect, USA
15:35	S05.5*	From the Lung to the Heart: Fatal Dissemination of Azole-Resistant Aspergillus Fumigatus in a Lung Transplant Patient
		Rose-Anne Lavergne, France
Symposium 6		Prophylaxis during Hematology Malignancies
		Chairs: Livio Pagano, FEMCC, Italy & Oliver Cornely, FECMM, Germany
14:15	S06.1	AML—in the Era of FLT3 Inhibitors
		Russel Lewis, Italy
14:35	S06.2	ALL—There Is a Role for Prophylaxis
		Daniel Teschner, Germany
14:55	S06.3	Personalized Medicine/Approach by Genetic Risk Factors
		Pierre-Yves Bochud, Switzerland
15:15	S06.4	Baseline CT upon Diagnosis of Acute Leukemia
		Stefan Schwartz, Germany
15:35	S06.5*	Investigating the Impact of Posaconazole Prophylaxis on Systematic Fungal Screening Using Galactomannan Antigen, Aspergillus qPCR and Mucorales qPCR
		Anne-Pauline Bellanger, France
Symposium 7		Paediatric Mycology (EPMyN)
		Chairs: Emmanuel Roilides, FECMM, Greece & Roger Brüggemann, FECMM, The Netherlands
14:15	S07.1	Fluconazole and Micafungin Dosing in Neonates
		Roger Brüggemann, The Netherlands
14:35	S07.2	Antifungal Susceptibility of Pediatric Candidemia
		Zoi-Dorothea Pana, Greece
14:55	S07.3	Primary Immunodeficiencies Characterized by Fungal Infections
		Fanny Lanternier, FECMM, France
15:25	S07.5*	Isavuconazole use in pediatric hematoncologic patients: the Italian Association of Pediatric Hematology Oncology (AIEOP) experience
		Nunzia Decembrino, Italy
Symposium 8		Immunologic Markers for Diagnosis and Treatment Stratification in Invasive Mold Infection
		Chairs: Martin Hoenigl, FECMM, Austria & Agostinho Carvalho, FECMM, Portugal
14:15	S08.1	Antimold Immune Response: the Impact of the Host, the Pathogen, and Translational Implications
		Agostinho Carvalho, FECMM, Portugal
14:35	S08.2	Immunologic Markers for Diagnosis of Invasive Aspergillosis and Other Invasive Mold Infections
		Carol Garcia-Vidal, Spain
14:55	S08.3	Immunologic Markers For Treatment Stratification in Invasive Mold Infection
		Philipp Köhler, FECMM, Germany
15:15	S08.4	Fungal Translocation: From Persistent Inflammation to Non-AIDS Events
		Martin Hoenigl, FECMM, Austria
15:35	S08.5*	Immunological Characteristics of Broncho Alveolar Lavage in Neutropenic Patients with Invasive Aspergillosis
		Claire Aguilar, France
Symposium 9		Chronic Pulmonary Aspergillosis
		Chairs: David Denning, FECMM, United Kingdom & Aleksandra Barac, FECMM, Serbia
14:15	S09.1	Effect of Patient Immunodeficiencies on the Diagnostic Performance of Serological Assays to Detect Aspergillus-Specific Antibodies in Chronic Pulmonary Aspergillosis
		Elizabeth Hunter, UK
14:35	S09.2	Diagnosis of CPA. Where Do We Stand?
		Aleksandra Barac, FECMM, Serbia
14:55	S09.3	Current Treatment Options for CPA
		David Denning, FECMM, UK
15:15	S09.4	Future Directions
		David Denning, FECMM, UK
15:25	S09.5*	Raised Amphotericin B MIC in Aspergillus fumigatus Isolates from Patients with Chronic Pulmonary Aspergillosis
		Fiona Lynch, UK
16:15–17:45		Parallel Symposia 10–14
Symposium 10		Sensing the Host
		Chairs: Muriel Cornet, France & Mihai Mares, FECMM, Romania
16:15	S10.1	S10.1 Cell wall of Aspergillus fumigatus in murine lung tissue
		Thierry Fontaine, France
16:45	S10.2	Hybrid Histidine Kinases: Major Sensing Proteins in Pathogenic Fungi
		Nicolas Papon, France
17:15	S10.3	Adapting to the Host: How Candida Causes Bloodstream Infection
		Oliver Kurzai, Germany
Symposium 11		The Antifungal Pipeline
		Chairs: David Denning, FECMM, United Kingdom & Oliver Cornely, FECMM, Germany
16:15	S11.1	Olorofim—A Novel Mould-Active Antifungal (F2G)
		John Rex, FECMM, UK
16:40	S11.2	Fosmanogepix: A Novel, Broad Spectrum Antifungal Therapy in Clinical Development (Amplyx)
		Michael Hodges, USA
17:05	S11.3	Ibrexafungerp (formerly SCY-078) (Scynexis)
		David Angulo, USA
Symposium 12		Environment and Fungal Outbreaks
		Chairs: Jean-Pierre Gangneux, FECMM, France & Tom Chiller, USA
16:15	S12.1	Frogs
		Matthew Fisher, UK
16:35	S12.2	Cryptococcus gattii
		Ferry Hagen, FECMM, The Netherlands
16:55	S12.3	Natural Disasters
		Tom Chiller, US
17:15	S12.4	Genomic Sequencing
		Marie Desnos, France
17:35	S12.5*	Outbreak of Fluconazole-Resistant Candida Parapsilosis in a Hospital Ward: Arguments for Clonal Transmission and Environmental Persistence
		Arnaud Fekkar, France
Symposium 13		Fungal Respiratory Infections in Cystic Fibrosis (the ECMM/ISHAM Working Group Fri-CF)
		Chairs: Jean-Philippe Bouchara, France & Petr Hamal, Czech Republic
16:15	S13.1	Rasamsonia Species and Other Emerging Fungi in CF
		Solène Le Gal, France
16:35	S13.2	Immunodiagnosis of Scedosporium/Lomentospora Infection—Lessons from Immunoproteomic Studies
		Andoni Ramirez-Garcia, Spain
16:55	S13.3	Bacterial/Fungal Interactions in the CF Mucus
		Françoise Botterel, France
17:15	S13.4*	Morphology, Growth, and Biofilm Formation of the Black Yeast-Like Fungus Exophiala dermatitidis is Influenced by Pseudomonas aeruginosa under in Vitro Cystic Fibrosis Conditions
		Lisa Kirchhoff, Germany
17:25	S13.6*	Study of Antigenic Markers for Serological Detection of Scedosporium spp. in Cystic Fibrosis Patients
		Leire Martin-Souto, Spain
17:35		Discussion
Symposium 14		Teaching Medical Mycology: What, How, to Whom and When
		Chairs: Patricia Muñoz, Spain & Esther Segal, FECMM, Israel
16:15	S14.1	Mycology Teaching in Medical School—How Much, What to Choose, at What Level
		Peter Rath, FECMM, Germany
16:35	S14.2	Mycology Teaching in Medical School—Is Student Demography Important to What Should Be Taught?
		Ester Segal, FECMM, Israel
16:55	S14.3	Specific Courses Outside the European Continent—The Indian Example
		Ruth Ashbee, United Kingdom
17:15	S14.4	Teaching Clinical Laboratory Mycology—How and Who Is the Audience?
		Sevtap Arikan-Akdagli, FECMM, Turkey
17:35	S14.5	The African Example
		Aude Sturny, France